bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
Go back to bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year| (NASDAQ: BIAF) | Delayed: 0.64 +0.06 (10.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.58 | 52 Week High | $ | |||
| Open | $0.58 | 52 Week Low | $ | |||
| Day High | $0.66 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $ | |||
| Volume | 169,822 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $ | |||
| Open | $0.09 | 52 Week Low | $ | |||
| Day High | $0.09 | P/E | N/A | |||
| Day Low | $0.09 | EPS | $ | |||
| Volume | 6,620,741 | |||||

